anmelden
Novartis Aktie
132,00
EUR
+1,62
EUR
+1,24
%
132,04
EUR
+1,42
EUR
+1,09
%
Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novartis Aktie Analyse
| 19.07.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.07.24 | Novartis Hold | Deutsche Bank AG | |
| 03.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.05.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 25.03.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.02.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Novartis Neutral | UBS AG | |
| 03.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 05.12.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 28.11.23 | Novartis Neutral | UBS AG | |
| 24.10.23 | Novartis Neutral | UBS AG | |
| 19.10.23 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.10.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 04.10.23 | Novartis Neutral | UBS AG | |
| 25.09.23 | Novartis Equal-weight | Morgan Stanley | |
| 31.08.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.07.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.07.23 | Novartis Neutral | UBS AG | |
| 18.07.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 15.06.23 | Novartis Neutral | UBS AG | |
| 05.06.23 | Novartis Neutral | UBS AG | |
| 19.05.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.05.23 | Novartis Neutral | UBS AG | |
| 26.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 28.03.23 | Novartis Neutral | UBS AG | |
| 28.03.23 | Novartis Hold | Deutsche Bank AG | |
| 06.02.23 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.02.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 01.02.23 | Novartis Neutral | UBS AG | |
| 09.01.23 | Novartis Neutral | UBS AG | |
| 03.01.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 14.12.22 | Novartis Neutral | UBS AG | |
| 08.12.22 | Novartis Market-Perform | Bernstein Research | |
| 06.12.22 | Novartis Neutral | UBS AG | |
| 26.10.22 | Novartis Market-Perform | Bernstein Research | |
| 25.10.22 | Novartis Neutral | UBS AG | |
| 26.09.22 | Novartis Neutral | UBS AG | |
| 14.09.22 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.08.22 | Novartis Neutral | UBS AG | |
| 20.07.22 | Novartis Neutral | Credit Suisse Group | |
| 19.07.22 | Novartis Neutral | UBS AG | |
| 01.07.22 | Novartis Neutral | UBS AG | |
Werbung
Werbung